Tawbi, H. A., Hodi, F. S., Lipson, E. J., Schadendorf, D., Ascierto, P. A., Matamala, L., Gutiérrez, E. C., Rutkowski, P., Gogas, H., Lao, C. D., Menezes, J. J. D., Dalle, S., Arance, A. M., Grob, J., Ratto, B., Rodriguez, S., Mazzei, A., Dolfi, S., Long, G. V. (2025). Three-Year Overall Survival With Nivolumab Plus Relatlimab in Advanced Melanoma From RELATIVITY-047. Journal of Clinical Oncology. https://doi.org/10.1200/jco.24.01124